Literature DB >> 12116606

The effects of hormones on arrhythmias in women.

Michael S Bailey1, Anne B Curtis.   

Abstract

The reproductive hormones play a significant role in modulating the presentation and behavior of numerous types of arrhythmias. Differences exist between men and women in normal electrophysiology; along with heart rate, the QT interval is a basic parameter that is affected by the presence or absence of certain reproductive hormones. Women have a lower prevalence of atrial fibrillation, yet they have a higher mortality once atrial fibrillation is established. There are clear-cut gender differences in the prevalence of other re-entrant supraventricular tachycardias as well. Women are at lower risk of sudden cardiac death overall, but they have a higher risk of acquired long QT syndrome from antiarrhythmic drugs. It is possible that differences in myocardial repolarization modulated by sex hormones are a major factor in the differential presentation of these arrhythmias in men and women.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12116606

Source DB:  PubMed          Journal:  Curr Womens Health Rep        ISSN: 1534-5874


  12 in total

1.  Clinical characteristics of patients with sustained ventricular arrhythmias after sacubitril/valsartan initiation.

Authors:  Lourdes Vicent; Francisco Méndez-Zurita; Xavier Viñolas; Concepción Alonso-Martín; Carles Moliner Arbòs; Julia Pamies; R Oscar Alcalde; Miriam Juárez; Vanesa Bruña; Carolina Devesa; Iago Sousa-Casasnovas; Francisco Fernández-Avilés; Manuel Martínez-Sellés
Journal:  Heart Vessels       Date:  2019-06-22       Impact factor: 2.037

Review 2.  [Differences between men and women in side effects of second-generation antipsychotics].

Authors:  W Aichhorn; A B Whitworth; E M Weiss; H Hinterhuber; J Marksteiner
Journal:  Nervenarzt       Date:  2007-01       Impact factor: 1.214

Review 3.  Second-generation antipsychotics: is there evidence for sex differences in pharmacokinetic and adverse effect profiles?

Authors:  Wolfgang Aichhorn; Alexandra B Whitworth; Elisabeth M Weiss; Josef Marksteiner
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

4.  Gender issues in the pharmacotherapy of opioid-addicted women: buprenorphine.

Authors:  Annemarie Unger; Erika Jung; Bernadette Winklbaur; Gabriele Fischer
Journal:  J Addict Dis       Date:  2010-04

5.  Signal-averaged electrocardiogram in physically healthy, chronic 3,4-methylenedioxymethamphetamine (MDMA) users.

Authors:  Praveen Kanneganti; Marilyn A Huestis; Erin A Kolbrich; Robert Goodwin; Roy C Ziegelstein; David A Gorelick
Journal:  Am J Drug Alcohol Abuse       Date:  2008       Impact factor: 3.829

6.  Sex differences in the modulation of K+ currents in diabetic rat cardiac myocytes.

Authors:  Yakhin Shimoni; Xiu-Fang Liu
Journal:  J Physiol       Date:  2003-05-30       Impact factor: 5.182

7.  Cardiologic side effects of psychotropic drugs.

Authors:  Giuseppe Marano; Gianandrea Traversi; Enrico Romagnoli; Valeria Catalano; Marzia Lotrionte; Antonio Abbate; Giuseppe Biondi-Zoccai; Marianna Mazza
Journal:  J Geriatr Cardiol       Date:  2011-12       Impact factor: 3.327

Review 8.  The protective role of estrogen and estrogen receptors in cardiovascular disease and the controversial use of estrogen therapy.

Authors:  Andrea Iorga; Christine M Cunningham; Shayan Moazeni; Gregoire Ruffenach; Soban Umar; Mansoureh Eghbali
Journal:  Biol Sex Differ       Date:  2017-10-24       Impact factor: 5.027

9.  Long-term results of single-procedure catheter ablation for atrial fibrillationin pre- and post-menopausal women.

Authors:  Tao Lin; Xing Du; Rong Bai; Ying-Wei Chen; Rong-Hui Yu; De-Yong Long; Ri-Bo Tang; Cai-Hua Sang; Song-Nan Li; Chang-Sheng Ma; Jian-Zeng Dong
Journal:  J Geriatr Cardiol       Date:  2014-06       Impact factor: 3.327

10.  An epidemiological study on the prevalence of atrial fibrillation in the Chinese population of mainland China.

Authors:  Ziqiang Zhou; Dayi Hu
Journal:  J Epidemiol       Date:  2008-09-08       Impact factor: 3.211

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.